The Legal Services Corporation (LSC) launched the LSC Eviction Laws Database today in partnership with the Center for Public Health Law Research. The database is a new online tool that will aid users in better understanding the significant variation in eviction laws across the country and the effect these differences have on eviction outcomes.
With support from Vital Strategies, the Center for Public Health Law Research will expand four of its most popular datasets on the Prescription Drug Abuse Policy System (PDAPS) at PDAPS.org.
New data released captures insurance coverage mandates of contraception in all 50 U.S. states and the District of Columbia in effect from January 1, 2016 through December 31, 2021.
In a new commentary in Contraception, the authors argue that permanently lifting the FDA’s Risk Evaluation and Mitigation Strategy (REMS) for mifepristone in its entirety would expand access to early abortion and miscarriage care.
Newly updated data show continued movement in US states to restrict access to abortion services, medication abortion, and telemedicine for abortion.
The Center for Public Health Law Research is hiring!
Juan Hincapie-Castillo, PharmD, PhD, an assistant professor of pharmaceutical outcomes and policy in the University of Florida College of Pharmacy, has been appointed as a Center for Public Health Law Research Fellow for a two-year term.
Two new datasets published to LawAtlas.org today offer a comprehensive look at state laws that address earned sick leave and Ban the Box. The datasets provide a snapshot of how these employment-focused laws differ between states, and highlight opportunities for states to expand these evidence-based regulations.
Across the US, states are increasingly using preemption to stymie local advancement of public health policy strategies, according to updated data released to LawAtlas.org by the Center for Public Health Law Research and the National League of Cities with support from the Robert Wood Johnson Foundation.
As states continue facing rising opioid-related deaths, particularly amid the COVID-19 pandemic, many are missing opportunities to provide access to proven treatment through medications for opioid use disorder (MOUD), according to new data released to PDAPS.org by the Center for Public Health Law Research.